alexa Left ventricular reconstruction concomitant to coronary artery bypass grafting: when and how?
Microbiology

Microbiology

Journal of Microbial & Biochemical Technology

Author(s): Menicanti L, Castelvecchio S

Abstract Share this page

Abstract PURPOSE OF REVIEW: The increase in left ventricular (LV) volume after a myocardial infarction is a component of the remodeling process and it is associated with a poor clinical outcome. Hence, the current management strategy for ischemic LV dysfunction has been aimed to reverse the remodeling process (i.e., reduction of LV volume and improved ejection fraction) by medical and/or device therapy. Surgical left ventricular reconstruction (LVR) has been introduced as an optional therapeutic strategy aimed to reduce LV volumes through the exclusion of the scar tissue, thereby restoring the physiological volume and shape and improving LV function and clinical status. RECENT FINDINGS: Until recently, LVR was being increasingly performed and a large number of reports drawn on various data sets from registries and mainly observational studies have shown that LVR is effective and relatively safe with a favourable 5-year outcome. However, the most recent released results from the Surgical Treatment for Ischemic Heart Failure (STICH) trial, which showed no difference in the occurrence of the primary endpoint between patients treated with coronary artery bypass grafting (CABG) alone or CABG along with LVR, have called into question the additional benefit of the LV surgical reconstruction. SUMMARY: LVR has recently been endorsed by the European Task Force on Myocardial Revascularization to be considered as a surgical option combined with CABG in selected patients affected by ischemic heart failure and LV dysfunction, mainly in centers with a high level of surgical expertise. This article was published in Curr Opin Cardiol and referenced in Journal of Microbial & Biochemical Technology

Relevant Expert PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords